Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States

Ashley Pariser,Tannaz Sedghi,Pamela R. Soulos,Brigid K. Killelea,Cary P. Gross,Sarah S. Mougalian

Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States

2019

Ashley Pariser
Tannaz Sedghi
Pamela R. Soulos
Brigid K. Killelea
Cary P. Gross
Sarah S. Mougalian

Purpose To evaluate if real-world utilization of neoadjuvant endocrine therapy (NET) is associated with similar rates of response and breast conservation surgery (BCS) compared to neoadjuvant chemotherapy (NAC).

Keywords:

Breast conservation therapy
Oncology
Medicine
Endocrine system
Internal medicine
Cancer research
Chemotherapy
Neoadjuvant therapy
Logistic regression
T-stage
Confidence interval
Odds ratio
Population
Odds
Endocrinology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations